R. Soikes

Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses

Mariano J. Alvarez, Sonali M. Smith, A. Califano, 2021, British journal of haematology.

324 Preclinical evaluation of anti-VISTA antibody CI-8993 in a syngeneic huVISTA-KI model

A. Rigopoulos, I. Burvenich, R. Roemeling, 2021, Journal for ImmunoTherapy of Cancer.